Paclitaxel ⚖️ PAD 🚫 Promise or Peril?
Dr RR Baliga's "Got Knowledge Doc" Podkast
September 28, 20257m 39s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🚨 New Evidence Alert 🚨
The SWEDEPAD 1 & 2 trials + a powerful Lancet commentary have reshaped how we view paclitaxel-coated devices in peripheral artery disease.
👉 No benefit for amputation or quality of life.
👉 A concerning signal for higher 5-year mortality in claudication.
👉 Registry-based RCTs prove invaluable for real-world insights.
⚖️ Message: Harm may outweigh benefit — time to rethink strategies and explore alternatives like sirolimus.
#PAD #ClinicalTrials #Cardiology #SWEDEPAD 🫀